The Chinese online tuition provider which counts Tencent, Longfor Properties, Yuanfudao and Kuaishou as investors, has filed to raise $100m in a US offering.

NTT Docomo is set to exit the database technology provider in a flotation on the Nasdaq Global Select Market that will follow some $250m of venture funding.

Samsung, Delphi and Sensata-backed lidar technology developer will get a New York Stock Exchange listing through the deal, conducted at a $1.4bn valuation.

Salesforce-backed lending software producer Blend has raised more than $685m in funding and hit a $3.3bn valuation in its last funding round five months ago.

Bayer and Fujifilm scored exits as the cancer treatment developer floated on the Nasdaq Global Select Market at the top of its range.

The cancer therapy developer and Jackson Laboratory spinout floated at the upper end of its range and now has a $600m market cap.

Novo and Celgene will retain shares in the cancer therapy developer, which floated at the upper end of its range and which now has a $600m market cap.

The antibody-based drug developer, which counts WuXi AppTec, Fosun, Sinopharm and Humanwell as investors, has floated in a $126m offering.

The GlaxoSmithKline and Celgene-backed immunotherapy developer has floated in the middle of its range on the Nasdaq Global Market.

The Mitsui-backed money transfer service formerly known as TransferWise was valued at $5bn in a secondary share sale almost a year ago.